Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
40.14
+1.74 (4.53%)
Nov 20, 2024, 4:00 PM EST - Market closed

Legend Biotech Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Jan '20 2019 - 2018
Operating Revenue
514.11284.96116.6865.47559.98
Upgrade
Other Revenue
6.070.180.333.42-1.82
Upgrade
Revenue
520.18285.14117.0168.837561.8
Upgrade
Revenue Growth (YoY)
122.96%143.70%70.00%-8.23%21.36%24.86%
Upgrade
Cost of Revenue
607.9526.43401.01313.35232.16-
Upgrade
Gross Profit
-87.72-241.29-284.01-244.52-157.1661.8
Upgrade
Selling, General & Admin
263.52200.93174.05149.572.7132.37
Upgrade
Research & Development
-----161.94
Upgrade
Operating Expenses
263.52200.93174.05149.572.71194.31
Upgrade
Operating Income
-351.24-442.22-458.05-394.02-229.87-132.51
Upgrade
Interest Expense
-22.28-21.79-10.8-0.9-0.2-0.22
Upgrade
Interest & Investment Income
64.8554.498.180.972.934.58
Upgrade
Currency Exchange Gain (Loss)
-10.14---0.070.58
Upgrade
Other Non Operating Income (Expenses)
-26.29-111.0314.82-12.27-1.23-0.22
Upgrade
EBT Excluding Unusual Items
-345.1-520.56-445.85-406.22-228.29-127.79
Upgrade
Gain (Loss) on Sale of Investments
-0.130.660.6-0.050.47
Upgrade
Gain (Loss) on Sale of Assets
-0.23-0.23-0.48-0.97-0.06-
Upgrade
Other Unusual Items
-----79.98-
Upgrade
Pretax Income
-345.46-520.12-445.72-407.2-308.29-127.32
Upgrade
Income Tax Expense
2.67-1.860.63-3.61-41.91-25.73
Upgrade
Net Income
-348.13-518.25-446.35-403.58-266.37-101.59
Upgrade
Net Income to Common
-348.13-518.25-446.35-403.58-266.37-101.59
Upgrade
Shares Outstanding (Basic)
182176159141118100
Upgrade
Shares Outstanding (Diluted)
182176159141118100
Upgrade
Shares Change (YoY)
6.16%10.71%12.91%19.21%18.15%-
Upgrade
EPS (Basic)
-1.91-2.94-2.81-2.87-2.25-1.02
Upgrade
EPS (Diluted)
-1.92-2.94-2.81-2.87-2.26-1.02
Upgrade
Free Cash Flow
-173.67-413.36-222.21-240.66-249.26-109.84
Upgrade
Free Cash Flow Per Share
-0.95-2.35-1.40-1.71-2.11-1.10
Upgrade
Gross Margin
-16.86%-84.62%-242.73%--209.55%100.00%
Upgrade
Operating Margin
-67.52%-155.09%-391.48%-572.49%-306.49%-214.42%
Upgrade
Profit Margin
-66.92%-181.75%-381.48%-586.38%-355.16%-164.39%
Upgrade
Free Cash Flow Margin
-33.39%-144.97%-189.91%-349.67%-332.35%-177.73%
Upgrade
EBITDA
-340.56-431.51-447.88-385.88-223.63-129.35
Upgrade
EBITDA Margin
-65.47%-151.33%---298.17%-209.31%
Upgrade
D&A For EBITDA
10.6810.710.178.146.233.16
Upgrade
EBIT
-351.24-442.22-458.05-394.02-229.87-132.51
Upgrade
EBIT Margin
-67.52%-155.09%----214.42%
Upgrade
Revenue as Reported
520.18285.14117.0168.8375-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.